This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stove, S. Articles by Kohl, J. Search for Related Content PubMed PubMed Citation Articles by Stove, S. Articles by Kohl, J.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, 03 1996, 175-183, Vol 3, No. 2
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome

S Stove, T Welte, TO Wagner, A Kola, A Klos, W Bautsch and J Kohl
Institute of Medical Microbiology, Medical School Hannover, Germany.

The systemic inflammatory response of the body to invading microorganisms, termed sepsis, leads to profound activation of the complement system. Pathophysiological concepts suggest that complement activation occurs very early in this syndrome. Thus, we discuss whether the determination of concentrations of the complement components C3a, C5a, and C3 in plasma as well as of the C3a/C3 ratio might be helpful to diagnose sepsis early. For this purpose, 33 patients from an intensive care unit were monitored for 10 days. In comparison with healthy donors, C3a levels and the C3a/C3 ratio of intensive-care-unit patients were significantly elevated (P < 0.0001) on admission. In contrast, C3 levels were significantly reduced (P < 0.0001) but increased during the study. C5a levels in the plasma of healthy donors and patients were identical. Twenty-two of 33 patients fulfilled microbiological and clinical criteria of sepsis. Eleven patients had signs of systemic inflammatory response syndrome but no microbiological evidence of sepsis. The groups could be differentiated from each other by their C3a levels or their C3a/C3 ratios during the first 24 h after the clinical onset of sepsis (P < 0.05). Septic patients in shock had higher C3a levels than normotensive septic patients, although the differences were not significant. Nonsurvivors had significantly higher C3a levels on admission than survivors (P = 0.0185). No differences were found between septic patients who developed adult respiratory distress syndrome and those who did not. Thus, determination of C3a concentrations in plasma may prove useful (i) to diagnose sepsis early, (ii) to differentiate between patients with sepsis and those with systemic inflammatory response syndrome, and (iii) to assess prognosis.

This article has been cited by other articles:

• Nordahl, E. A., Rydengard, V., Nyberg, P., Nitsche, D. P., Morgelin, M., Malmsten, M., Bjorck, L., Schmidtchen, A. (2004). Activation of the complement system generates antibacterial peptides. Proc. Natl. Acad. Sci. USA 101: 16879-16884 [Abstract] [Full Text]  
• Asai, S., Sato, T., Tada, T., Miyamoto, T., Kimbara, N., Motoyama, N., Okada, H., Okada, N. (2004). Absence of Procarboxypeptidase R Induces Complement-Mediated Lethal Inflammation in Lipopolysaccharide-Primed Mice. J. Immunol. 173: 4669-4674 [Abstract] [Full Text]  
• Laudes, I. J., Chu, J. C., Huber-Lang, M., Guo, R.-F., Riedemann, N. C., Sarma, J. V., Mahdi, F., Murphy, H. S., Speyer, C., Lu, K. T., Lambris, J. D., Zetoune, F. S., Ward, P. A. (2002). Expression and Function of C5a Receptor in Mouse Microvascular Endothelial Cells. J. Immunol. 169: 5962-5970 [Abstract] [Full Text]  
• Pfeifer, P. H., Kawahara, M. S., Hugli, T. E. (1999). Possible Mechanism for in Vitro Complement Activation in Blood and Plasma Samples: Futhan/EDTA Controls in Vitro Complement Activation. Clin. Chem. 45: 1190-1199 [Abstract] [Full Text]  
• van den Berg, R. H., Faber-Krol, M. C., van Wetering, S., Hiemstra, P. S., Daha, M. R. (1998). Inhibition of Activation of the Classical Pathway of Complement by Human Neutrophil Defensins. Blood 92: 3898-3903 [Abstract] [Full Text]  
• Hartmann, K., Henz, B. M., Kruger-Krasagakes, S., Kohl, J., Burger, R., Guhl, S., Haase, I., Lippert, U., Zuberbier, T. (1997). C3a and C5a Stimulate Chemotaxis of Human Mast Cells. Blood 89: 2863-2870 [Abstract] [Full Text]